These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 11079671)

  • 21. Brugada syndrome with ventricular tachycardia and fibrillation related to hypokalemia.
    Araki T; Konno T; Itoh H; Ino H; Shimizu M
    Circ J; 2003 Jan; 67(1):93-5. PubMed ID: 12520160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term follow-up of asymptomatic Brugada patients with inducible ventricular fibrillation under hydroquinidine.
    Bouzeman A; Traulle S; Messali A; Extramiana F; Denjoy I; Narayanan K; Marijon E; Hermida JS; Leenhardt A
    Europace; 2014 Apr; 16(4):572-7. PubMed ID: 24068450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ventricular fibrillation triggered by PVCs from papillary muscles: clinical features and ablation.
    Santoro F; Di Biase L; Hranitzky P; Sanchez JE; Santangeli P; Perini AP; Burkhardt JD; Natale A
    J Cardiovasc Electrophysiol; 2014 Nov; 25(11):1158-64. PubMed ID: 24946987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-Term Outcomes of Brugada Substrate Ablation: A Report from BRAVO (Brugada Ablation of VF Substrate Ongoing Multicenter Registry).
    Nademanee K; Chung FP; Sacher F; Nogami A; Nakagawa H; Jiang C; Hocini M; Behr E; Veerakul G; Jan Smit J; Wilde AAM; Chen SA; Yamashiro K; Sakamoto Y; Morishima I; Das MK; Khongphatthanayothin A; Vardhanabhuti S; Haissaguerre M
    Circulation; 2023 May; 147(21):1568-1578. PubMed ID: 36960730
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vagal activity modulates spontaneous augmentation of ST elevation in the daily life of patients with Brugada syndrome.
    Mizumaki K; Fujiki A; Tsuneda T; Sakabe M; Nishida K; Sugao M; Inoue H
    J Cardiovasc Electrophysiol; 2004 Jun; 15(6):667-73. PubMed ID: 15175062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electrical storm in Brugada syndrome successfully treated using isoprenaline.
    Maury P; Couderc P; Delay M; Boveda S; Brugada J
    Europace; 2004 Mar; 6(2):130-3. PubMed ID: 15018871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive impact of the inducibility of ventricular fibrillation in patients with Brugada-type ECG.
    Imaki R; Niwano S; Fukaya H; Sasaki S; Yuge M; Hirasawa S; Sato D; Sasaki T; Moriguchi M; Izumi T
    Int Heart J; 2006 Mar; 47(2):229-36. PubMed ID: 16607050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paced QRS fragmentation is associated with spontaneous ventricular fibrillation in patients with Brugada syndrome.
    Kataoka N; Mizumaki K; Nakatani Y; Sakamoto T; Yamaguchi Y; Tsujino Y; Nishida K; Inoue H
    Heart Rhythm; 2016 Jul; 13(7):1497-503. PubMed ID: 27018377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the necessity for cardioverter-defibrillator implantation in elderly patients with Brugada syndrome.
    Kamakura T; Wada M; Nakajima I; Ishibashi K; Miyamoto K; Okamura H; Noda T; Aiba T; Takaki H; Yasuda S; Ogawa H; Shimizu W; Makiyama T; Kimura T; Kamakura S; Kusano K
    Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):785-91. PubMed ID: 26067668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Brugada syndrome--an update.
    Shimizu W
    Intern Med; 2005 Dec; 44(12):1224-31. PubMed ID: 16415541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of stored implanted cardiac defibrillator electrograms in catheter ablation of ventricular fibrillation.
    Lowery CM; Tzou WS; Aleong RG; Nguyen DT; Varosy PD; Katz DF; Heath RR; Schuller JL; Lewkowiez L; Sauer WH
    Pacing Clin Electrophysiol; 2013 Jan; 36(1):76-85. PubMed ID: 23078144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience.
    Conte G; Sieira J; Ciconte G; de Asmundis C; Chierchia GB; Baltogiannis G; Di Giovanni G; La Meir M; Wellens F; Czapla J; Wauters K; Levinstein M; Saitoh Y; Irfan G; Julià J; Pappaert G; Brugada P
    J Am Coll Cardiol; 2015 Mar; 65(9):879-88. PubMed ID: 25744005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unsuccessful internal defibrillation in Brugada syndrome: focus on refractoriness and ventricular fibrillation cycle length.
    Watanabe H; Chinushi M; Sugiura H; Washizuka T; Komura S; Hosaka Y; Furushima H; Watanabe H; Hayashi J; Aizawa Y
    J Cardiovasc Electrophysiol; 2005 Mar; 16(3):262-6. PubMed ID: 15817083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrocardiographic parameters and fatal arrhythmic events in patients with Brugada syndrome: combination of depolarization and repolarization abnormalities.
    Tokioka K; Kusano KF; Morita H; Miura D; Nishii N; Nagase S; Nakamura K; Kohno K; Ito H; Ohe T
    J Am Coll Cardiol; 2014 May; 63(20):2131-2138. PubMed ID: 24703917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of quinidine in high-risk patients with Brugada syndrome.
    Belhassen B; Glick A; Viskin S
    Circulation; 2004 Sep; 110(13):1731-7. PubMed ID: 15381640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.
    Priori SG; Gasparini M; Napolitano C; Della Bella P; Ottonelli AG; Sassone B; Giordano U; Pappone C; Mascioli G; Rossetti G; De Nardis R; Colombo M
    J Am Coll Cardiol; 2012 Jan; 59(1):37-45. PubMed ID: 22192666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sinus rhythm R-wave amplitude as a predictor of ventricular fibrillation undersensing in patients with implantable cardioverter-defibrillator.
    Ruetz LL; Koehler JL; Brown ML; Jackson TE; Belk P; Swerdlow CD
    Heart Rhythm; 2015 Dec; 12(12):2411-8. PubMed ID: 26272520
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ventricular arrhythmias detected after transvenous defibrillator implantation in patients with a clinical history of only ventricular fibrillation. Implications for use of implantable defibrillator.
    Raitt MH; Dolack GL; Kudenchuk PJ; Poole JE; Bardy GH
    Circulation; 1995 Apr; 91(7):1996-2001. PubMed ID: 7895358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is the Brugada syndrome?
    Corrado D; Buja G; Basso C; Nava A; Thiene G
    Cardiol Rev; 1999; 7(4):191-5. PubMed ID: 10423670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.